IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Decheng Capital LLC

Q2 2025 Holdings

Filed 2025-08-13 | 25 holdings | $396.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
CG Oncology Inc(CGON)COM156944100$165.7M6,371,66941.8%
Aardvark Therapeutics Inc(AARD)COM002942100$53.0M3,917,29913.4%
Nuvation Bio Inc.(NUVB)COM67080N101$50.6M25,954,43912.8%
Upstream Bio Inc.(UPB)COM91678A107$36.1M3,285,2939.1%
Newamsterdam Pharma Co NV(NAMS)COMN62509109$13.9M770,0003.5%
BeyondSpring Inc.(BYSI)SHSG10830100$10.6M4,531,4812.7%
Merus NVCOMN5749R100$9.9M189,0982.5%
Krystal Biotech Inc(KRYS)COM501147102$9.1M66,0002.3%
Moonlake ImmunotherapeuticsCOMG4444C102$8.6M181,6002.2%
Revolution Medicines Inc(nsm)(RVMD)COM76155X100$8.3M226,0002.1%
Aclaris Therapeutics, Inc.(ACRS)COM00461U105$5.7M4,041,7361.4%
Lyell Immunopharma, Inc.COM55083R104$5.3M595,4661.3%
Arcellx Inc(ACLX)COM03940C100$4.5M547,6091.1%
Crinetics Pharmaceuticals in(CRNX)COM22663K107$4.1M143,0001.0%
Aura Biosciences, Inc.(AURA)COM05153U107$3.2M515,5550.8%
Zentalis Pharmaceuticals Inc.(ZNTL)COM98943L107$1.5M1,323,3270.4%
Equillium Inc.(EQ)COM29446K106$1.4M4,447,3080.4%
4D Molecular Therapeutics in(FDMT)COM35104E100$888.6K239,5100.2%
Arcus Biosciences, Inc(RCUS)COM03969F109$811.2K160,0000.2%
Illumnia, Inc.(ILMN)COM452327109$761.3K7,9790.2%
Legend Biotech Corp(LEGN)ADR52490G102$709.8K20,0000.2%
Grail Inc(GRAL)COM384747101$498.0K9,6840.1%
Pyxis Oncology, Inc (formerly Apexigen)(PYXS)COM747324101$359.5K326,8100.1%
Rezolute Inc(RZLT)COM76200L309$267.2K59,9000.1%
Nuvation Bio Inc.(NUVB/WS)WARRANTS67080N119$127.3K646,0570.0%